Finding the way forward
for safer medicines.
On the path to ever-improving safety, we’re a not-for-profit
partner
that’s guided by the things that matter most: the needs
of our partners and the patients they serve.
We use real-world data and apply the expertise
we’ve gathered across four decades to advance our
understanding of safety and risk.
We are The Drug Safety Research Unit.
Real World Data Solutions
Engage the DSRU to meet your pharmacovigilance and pharmacoepidemiology requirements.
Consulting at DSRU
Expertise in pharmacovigilance, pharmacoepidemiology & risk management.
Education & Training
Make yourself a prime candidate for the role you aspire to by studying with DSRU.
Across pharmacovigilance and pharmacoepidemiology research and education, we share our deep experience and regulator-trusted methodologies, collaborating to set standards throughout the sector.
Our studies bring clarity and confidence to organisations that develop, provide or regulate medicines and vaccines and, in turn, the people who use them. And our specialist education and training helps develop pharmacovigilance professionals, encouraging future best practice approaches. With data as our backbone and scientific rigour our core, we identify actionable insights across utilisation, safety, and risk, creating meaningful change through in-depth evidence for safer medicines.
Linda Härmark
Director
News & press
Latest news & press releases from DSRU
The DSRU team is at the PIPA 2026 Annual Conference
Alison Evans, Sandeep Dhanda, and Miranda Davies recently enjoyed an inspiring experience at the Pharmacovigilance Day during the PIPA 2026...
A few reflections following a very rewarding ISPE 2026 in Milan
Peter Arlett’s keynote provided a strong opening to the meeting, highlighting the evolving role of real-world evidence alongside clinical trials...
Safety surveillance of influenza vaccine in children
Our latest publication in Vaccine reports on Enhanced Passive Safety Surveillance (EPSS) of Fluenz® Tetra in children across eight influenza...
DSRU welcomes their new look!
For more than four decades, our work has been guided by one thing above all: the needs of our partners...
DSRU looks forward to ISPE conference!
The DSRU team is off to Milan on 30th August for the 42nd Annual Meeting of the International Society for...
Shaping Vaccine Safety Evidence Across Europe
DSRU colleagues have contributed to a major VAC4EU study examining thrombosis with thrombocytopaenia syndrome (TTS) — a rare blood clotting...Testimonials
What our stakeholders are saying about us
Aims to protect patients from undesirable adverse effects of medicines in clinical use
I am very satisfied with the work and involvement that DSRU personnel has in the ***** studies. DSRU are very well known and highly regarded in the pharmaceutical industry. The support they have given to ***** is of the highest possible quality. DSRU have the best professionals for data analysis from epi studies and they have proven it again with the ***** project. The quality of work is impeccable.
A pleasure to work with
Highly collaborative and highly ethical, and a pleasure to work with.